Navigation Links
Bayer HealthCare Provides Nearly $2.5 Million to Advance Hemophilia Research and Patient Care
Date:7/28/2011

WAYNE, N.J., July 28, 2011 /PRNewswire/ -- Bayer HealthCare today announced the 2011 recipients of the Bayer Hemophilia Awards Program (BHAP).  This year, the company has awarded nearly $2.5 million in funding to 18 recipients from 12 countries, including the U.S.  BHAP, the largest program of its kind for the hemophilia community, was created to help improve the understanding and treatment of hemophilia and related bleeding disorders.  The program also seeks to reduce the disease's impact on individuals and their communities, and support the next generation of care and treatment options worldwide for people with hemophilia.

BHAP supports research in bleeding disorders, ranging from studies to better understand inhibitor development and methods for treatment, gene therapy and joint care to the development of pediatric care models in underserved markets and hemophilia counseling.

"We're very pleased to award and congratulate these future hemophilia thought leaders for their exemplary passion, talent and expertise," said John E. Murphy, Ph.D., Director, Molecular Biology, Biologics Research, Bayer HealthCare. "BHAP is a reflection of Bayer's commitment to expanding the scientific and clinical knowledge that improves patient care."

The 2011 BHAP recipients were selected by a global committee of distinguished hemophilia clinicians, researchers and caregivers, and were honored at the BHAP award ceremony held in conjunction with the International Society of Thrombosis and Haemostasis (ISTH) Annual Meeting in Kyoto, Japan.  Among this year's winners are:

  • Dr. John Sheehan of the University of Wisconsin, for "Contribution of the heparin binding exosite to factor IX clearance and in vivo activity"
  • Dr. Carol Miao, Seattle Children's Research Institute, for "Immunimodulation to eradicate anti-factor VIII inhibitory antibodies"
  • Dr. Paris Margaritis, The Children's Hospital of
    '/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  New York College of Health ... Intellectual Properties portfolio with U.S. Patent #8,996,098 donated by ... patent represents a surgical instrument that allows surgeons to ... it were in the traditional format of a slide ... medical databases during surgery, thus providing the surgeon real ...
(Date:3/30/2015)... , March 30, 2015 DURECT Corporation ... has initiated a multi-dose Phase 1 clinical trial ... molecule in DURECT,s Epigenomic Regulator Program.  DUR-928 is ... may have broad applicability in metabolic diseases such ... steatohepatitis (NASH).  It may also play an important ...
(Date:3/30/2015)... Nutrastar International Inc. (OTCQB: NUIN) ("Nutrastar" or ... branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), ... announced its results for the full year ended December ... Full Year Ended December 31, 2014   ... to $43.35 million in full year 2013. ...
Breaking Medicine Technology:World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
... Biotechnology Company updates progress and upcoming,milestones on ... 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics Inc. , a ... for metabolic and cardiovascular disease,today announced positive ... human insulin. The Company,presented its findings at ...
... Tolerability Profile,in Subjects with Type 2 Diabetes ... /PRNewswire-FirstCall/ -- Phase III data,presented this week ... Diabetes,Association demonstrated that saxagliptin, an inhibitor of,dipeptidyl-peptidase-4 ... BMY) and AstraZeneca (NYSE: AZN), in,combination with ...
Cached Medicine Technology:SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6
(Date:3/30/2015)... NAPW honors Stacey ... the Year. Ms. Irey is recognized with this prestigious ... networking organization of professional women in the country, spanning ... Professional Women is a powerfully vibrant networking community with ... “I take care of four offices, 24 employees and ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 The ... an advocate for the provision of high-quality health ... through its survey and accreditation programs for 35 ... research, AAAHC aims to promote excellence in patient ... undergo rigorous self-assessments and on-site evaluations by AAAHC ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Healthpointe ... screens for employers and companies throughout Southern ... applicants are using drugs. It can identify evidence ... drugs. Employers, sports teams, D.O.T. applicants, and students regularly ... , The features of the drug screen program at ...
(Date:3/30/2015)... March 30, 2015 Foundations Recovery Network, ... announce the start of its 41st national conference by ... McGonigal, and former Congressman Patrick J. Kennedy as keynote ... being held in San Diego, CA, March 30 - ... national conference brings together leading experts specializing in the ...
(Date:3/30/2015)... Falls Church, VA (PRWEB) March 30, 2015 ... aseptic fill sites and flexible biological manufacturing plants. This ... trends in the business. , This has forced facilities ... lifespan. , The existing facilities have been forced ... have undergone a change of ownership. , Most of ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:Drug Screens Now at Healthpointe 2Health News:Drug Screens Now at Healthpointe 3Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3
... , SANTA ROSA, Calif., Sept. 21 Osseon ... cement delivery needle) and Osseoflex DR (steerable and curvable bone ... for marketing and clinical use in the European Union. , ... FDA approval in the United States, and allows for the ...
... , PEMBROKE, Bermuda, Sept. 21 ... announced today that Linda,McSmith, AVP, Risk Management for Allied World ... Allied World, at the Ohio Association of,Ambulatory Surgery Centers (OAASC) ... September 24-25, 2009. , Ms. McSmith,s ...
... , , , ... Inc. ("Astellas"), in partnership with the National Science Teachers Association ... science teachers to participate in the 2009 NSTA New Science ... to a range of tools and resources, while providing the ...
... , , PHILADELPHIA and LONDON, Sept. 21 ... that provides a unique combination of competitive intelligence and sales forecast ... of pipeline and marketed drugs . The product will be ... on October 8 and 9, and Bio Europe 2009 in Vienna ...
... N.C. The Defense Advanced Research Projects Agency (DARPA), the ... Duke University $19.5 million for an effort led by the ... a portable, easy-to-use diagnostic device that can reveal who is ... or sneeze. DARPA is interested in such a ...
... research and real world operation of electronic medical ... have developed, tested and are now operating innovative ... evidence-based medical information between clinical sources and public ... new tools developed by the Regenstrief Institute that ...
Cached Medicine News:Health News:Osseon Receives CE Mark 2Health News:Allied World's Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 2Health News:Allied World's Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 3Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 2Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 3Health News:Thomson Reuters Launches Thomson Pharma Partnering Forecast 2Health News:DARPA awards Duke $19.5 million to detect viral infection before symptoms appear 2Health News:Fighting disease outbreaks with 2-way health information exchange 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: